CN1652796A - 使用雌激素和抑制硫酸酯酶的孕激素的长周期避孕给药方案 - Google Patents

使用雌激素和抑制硫酸酯酶的孕激素的长周期避孕给药方案 Download PDF

Info

Publication number
CN1652796A
CN1652796A CNA038107104A CN03810710A CN1652796A CN 1652796 A CN1652796 A CN 1652796A CN A038107104 A CNA038107104 A CN A038107104A CN 03810710 A CN03810710 A CN 03810710A CN 1652796 A CN1652796 A CN 1652796A
Authority
CN
China
Prior art keywords
progestogen
days
ngmn
estrogen
ngm
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CNA038107104A
Other languages
English (en)
Chinese (zh)
Inventor
P·M·科贝尔
A·J·弗里德曼
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Janssen Pharmaceutica NV
Original Assignee
Janssen Pharmaceutica NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica NV filed Critical Janssen Pharmaceutica NV
Publication of CN1652796A publication Critical patent/CN1652796A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A61K9/0036—Devices retained in the vagina or cervix for a prolonged period, e.g. intravaginal rings, medicated tampons, medicated diaphragms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gynecology & Obstetrics (AREA)
  • Endocrinology (AREA)
  • Dermatology (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CNA038107104A 2002-03-11 2003-03-11 使用雌激素和抑制硫酸酯酶的孕激素的长周期避孕给药方案 Pending CN1652796A (zh)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US36316702P 2002-03-11 2002-03-11
US60/363,167 2002-03-11
US38158502P 2002-05-17 2002-05-17
US60/381,585 2002-05-17

Publications (1)

Publication Number Publication Date
CN1652796A true CN1652796A (zh) 2005-08-10

Family

ID=28045287

Family Applications (1)

Application Number Title Priority Date Filing Date
CNA038107104A Pending CN1652796A (zh) 2002-03-11 2003-03-11 使用雌激素和抑制硫酸酯酶的孕激素的长周期避孕给药方案

Country Status (6)

Country Link
EP (1) EP1482947A1 (ja)
JP (1) JP2005519963A (ja)
CN (1) CN1652796A (ja)
AU (1) AU2003218119A1 (ja)
CA (1) CA2478336A1 (ja)
WO (1) WO2003077926A1 (ja)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030219471A1 (en) * 2002-03-11 2003-11-27 Caubel Patrick Michel Extended cycle estrogen and sulfatase inhibiting progestogen contraceptive regimens
US8580294B2 (en) 2010-10-19 2013-11-12 International Partnership For Microbicides Platinum-catalyzed intravaginal rings
US10137031B2 (en) 2013-11-14 2018-11-27 International Partnership For Microbicides, Inc. Combination therapy intravaginal rings

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0836506T4 (da) * 1995-06-07 2012-01-30 Ortho Mcneil Pharm Inc Transdermalt plaster til indgivelse af 17-deacetyl norgestimat alene eller i kombination med et østrogen
CA2301162A1 (en) * 1997-09-12 1999-03-25 Michael Jay Gast Oral contraceptive preparation having a first phase comprising progestin/estrogen and a second phase comprising progestin

Also Published As

Publication number Publication date
CA2478336A1 (en) 2003-09-25
JP2005519963A (ja) 2005-07-07
AU2003218119A1 (en) 2003-09-29
WO2003077926A1 (en) 2003-09-25
EP1482947A1 (en) 2004-12-08

Similar Documents

Publication Publication Date Title
CN1652797A (zh) 连续使用抑制硫酸酯酶的孕激素的避孕给药方案
CN1652798A (zh) 连续抑制硫酸酯酶的孕激素的激素替代疗法
US5422119A (en) Transdermal hormone replacement therapy
CN1652799A (zh) 只用抑制硫酸酯酶的孕激素的避孕给药方案
US20150359802A1 (en) Parenteral pharmaceutical form which releases aromatse inhibitor and gestagens, for the treatment of endometriosis
CN1073422C (zh) 抗孕激素在制备减少子宫出血的药物中的应用
JPH02502724A (ja) 避妊を達成する組成物および方法
EP1928378A2 (en) Formulations and methods for providing progestin-only contraception while minimizing adverse side effects associated therewith
US20040142914A1 (en) Extended transdermal contraceptive regimens
US20030219471A1 (en) Extended cycle estrogen and sulfatase inhibiting progestogen contraceptive regimens
CN1652796A (zh) 使用雌激素和抑制硫酸酯酶的孕激素的长周期避孕给药方案
Sitruk-Ware Routes of delivery for progesterone and progestins
EP0675720A1 (en) Transdermal, multiphasic hormone replacement therapy

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C12 Rejection of a patent application after its publication
RJ01 Rejection of invention patent application after publication